Literature DB >> 11526241

Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment.

T Brabletz1, A Jung, S Reu, M Porzner, F Hlubek, L A Kunz-Schughart, R Knuechel, T Kirchner.   

Abstract

Invasion and dissemination of well-differentiated carcinomas are often associated with loss of epithelial differentiation and gain of mesenchyme-like capabilities of the tumor cells at the invasive front. However, when comparing central areas of primary colorectal carcinomas and corresponding metastases, we again found the same differentiated epithelial growth patterns. These characteristic phenotypic changes were associated with distinct expression patterns of beta-catenin, the main oncogenic protein in colorectal carcinomas, and E-cadherin. Nuclear beta-catenin was found in dedifferentiated mesenchyme-like tumor cells at the invasive front, but strikingly, as in central areas of the primary tumors, was localized to the membrane and cytoplasm in polarized epithelial tumor cells in the metastases. This expression pattern was accompanied by changes in E-cadherin expression and proliferative activity. On the basis of these data, we postulate that an important driving force for progression of well-differentiated colorectal carcinomas is the specific environment, initiating two transient phenotypic transition processes by modulating intracellular beta-catenin distribution in tumor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526241      PMCID: PMC56965          DOI: 10.1073/pnas.171610498

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells.

Authors:  O Tetsu; F McCormick
Journal:  Nature       Date:  1999-04-01       Impact factor: 49.962

Review 2.  General mechanisms of metastasis.

Authors:  E C Woodhouse; R F Chuaqui; L A Liotta
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

Review 3.  Tissue structure, nuclear organization, and gene expression in normal and malignant breast.

Authors:  M J Bissell; V M Weaver; S A Lelièvre; F Wang; O W Petersen; K L Schmeichel
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

4.  A causal role for E-cadherin in the transition from adenoma to carcinoma.

Authors:  A K Perl; P Wilgenbus; U Dahl; H Semb; G Christofori
Journal:  Nature       Date:  1998-03-12       Impact factor: 49.962

5.  Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells.

Authors:  J A Efstathiou; M Noda; A Rowan; C Dixon; R Chinery; A Jawhari; T Hattori; N A Wright; W F Bodmer; M Pignatelli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 6.  Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways.

Authors:  A I Barth; I S Näthke; W J Nelson
Journal:  Curr Opin Cell Biol       Date:  1997-10       Impact factor: 8.382

7.  Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.

Authors:  V J Wielenga; R Smits; V Korinek; L Smit; M Kielman; R Fodde; H Clevers; S T Pals
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

8.  Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas.

Authors:  B Mann; M Gelos; A Siedow; M L Hanski; A Gratchev; M Ilyas; W F Bodmer; M P Moyer; E O Riecken; H J Buhr; C Hanski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

9.  Identification of c-MYC as a target of the APC pathway.

Authors:  T C He; A B Sparks; C Rago; H Hermeking; L Zawel; L T da Costa; P J Morin; B Vogelstein; K W Kinzler
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

10.  Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.

Authors:  T Brabletz; A Jung; K Hermann; K Günther; W Hohenberger; T Kirchner
Journal:  Pathol Res Pract       Date:  1998       Impact factor: 3.250

View more
  431 in total

Review 1.  The cadherin-catenin adhesion system in signaling and cancer.

Authors:  Maralice Conacci-Sorrell; Jacob Zhurinsky; Avri Ben-Ze'ev
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  [Morphogenetic aspects of colorectal cancer].

Authors:  T Brabletz; T Kirchner
Journal:  Pathologe       Date:  2003-01-14       Impact factor: 1.011

Review 3.  The ins and outs of APC and beta-catenin nuclear transport.

Authors:  Beric R Henderson; Francois Fagotto
Journal:  EMBO Rep       Date:  2002-09       Impact factor: 8.807

4.  FOXO3a and β-catenin co-localization: double trouble in colon cancer?

Authors:  Yibing Yan; Mark R Lackner
Journal:  Nat Med       Date:  2012-06-06       Impact factor: 53.440

5.  MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.

Authors:  Keun Hur; Yuji Toiyama; Masanobu Takahashi; Francesc Balaguer; Takeshi Nagasaka; Junichi Koike; Hiromichi Hemmi; Minoru Koi; C Richard Boland; Ajay Goel
Journal:  Gut       Date:  2012-06-26       Impact factor: 23.059

Review 6.  The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?

Authors:  Simone Brabletz; Thomas Brabletz
Journal:  EMBO Rep       Date:  2010-08-13       Impact factor: 8.807

7.  Immunohistochemical analysis of the Wnt/β-catenin signaling pathway in pancreatic neuroendocrine neoplasms.

Authors:  Vivian Weiss; Julie Dueber; Jesse P Wright; Justin Cates; Frank Revetta; Alexander A Parikh; Nipun B Merchant; Chanjuan Shi
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

8.  ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.

Authors:  E Sánchez-Tilló; O de Barrios; E Valls; D S Darling; A Castells; A Postigo
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

9.  EGF enhances low-invasive cancer cell invasion by promoting IMP-3 expression.

Authors:  Xianglan Zhang; Im-Hee Jung; Young Sun Hwang
Journal:  Tumour Biol       Date:  2015-09-19

10.  MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.

Authors:  Junchao Cai; Hongyu Guan; Lishan Fang; Yi Yang; Xun Zhu; Jie Yuan; Jueheng Wu; Mengfeng Li
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.